Percutaneous ablation and the battle against primary lung cancer: A review of current techniques

Author(s): Gemma Marshall, Corey Frazer

Hospital: Harefield Hospital

Reference: RAD Magazine, 40, 464, 27-28


Lung cancer is the most common type of primary cancer worldwide. In the UK, less than 10% of people diagnosed with lung cancer will survive beyond five years and the disease is responsible for approximately 35,000 deaths per annum. In 2010, 34,859 patients died of lung cancer, 56% men, 44% women, Cancer Research UK.

Primary lung cancer is divided into two groups based on appearance of the histology sample. The two broad groups are small cell carcinoma (SCLC) and non-small cell carcinoma (NSCLC).

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more